M Michelle Berrey - Net Worth and Insider Trading

M Michelle Berrey Net Worth

The estimated net worth of M Michelle Berrey is at least $441,939 dollars as of 2023-09-24. M Michelle Berrey is the President and CEO of Chimerix Inc and owns about 424,941 shares of Chimerix Inc (CMRX) stock worth over $441,939. Details can be seen in M Michelle Berrey's Latest Holdings Summary section.

Transaction Summary of M Michelle Berrey


M Michelle Berrey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, M Michelle Berrey owns 3 companies in total, including Chimerix Inc (CMRX) , Intercept Pharmaceuticals Inc (ICPT) , and Ocean Biomedical Inc (OCEA) .

Click here to see the complete history of M Michelle Berrey’s form 4 insider trades.

Insider Ownership Summary of M Michelle Berrey

Ticker Comapny Transaction Date Type of Owner
CMRX Chimerix Inc 2013-04-10 Chief Medical Officer
ICPT Intercept Pharmaceuticals Inc 2021-06-14 President & R&D and CMO
OCEA Ocean Biomedical Inc 2023-02-14 director

M Michelle Berrey Latest Holdings Summary

M Michelle Berrey currently owns a total of 1 stock. M Michelle Berrey owns 424,941 shares of Chimerix Inc (CMRX) as of June 12, 2018, with a value of $441,939.

Latest Holdings of M Michelle Berrey

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CMRX Chimerix Inc 2018-06-12 424,941 1.04 441,939

Holding Weightings of M Michelle Berrey

M Michelle Berrey Form 4 Trading Tracker

According to the SEC Form 4 filings, M Michelle Berrey has made a total of 0 transactions in Chimerix Inc (CMRX) over the past 5 years. The most-recent trade in Chimerix Inc is the acquisition of 10,000 shares on June 12, 2018, which cost M Michelle Berrey around $45,000.

Insider Trading History of M Michelle Berrey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

M Michelle Berrey Trading Performance

GuruFocus tracks the stock performance after each of M Michelle Berrey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by M Michelle Berrey is 15.78%. GuruFocus also compares M Michelle Berrey's trading performance to market benchmark return within the same time period. The performance of stocks bought by M Michelle Berrey within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how M Michelle Berrey's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of M Michelle Berrey

Average Relative Return


Average relative return per transaction

Outperforming Transactions


4 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 15.31 15.78 27.73 40.66 0.81 -14.85
Relative Return to S&P 500(%) 13.17 10.95 20.74 27.5 -9.2 -26.07

M Michelle Berrey Ownership Network

Ownership Network List of M Michelle Berrey

No Data

Ownership Network Relation of M Michelle Berrey

M Michelle Berrey Owned Company Details

What does Chimerix Inc do?

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.

Who are the key executives at Chimerix Inc?

M Michelle Berrey is the Chief Medical Officer of Chimerix Inc. Other key executives at Chimerix Inc include Chief Medical Officer Allen S. Melemed , 10 percent owner Cantex Pharmaceuticals, Inc. , and Principal Accounting Officer David Jakeman .

Chimerix Inc (CMRX) Insider Trades Summary

Over the past 18 months, M Michelle Berrey made no insider transaction in Chimerix Inc (CMRX). Other recent insider transactions involving Chimerix Inc (CMRX) include a net purchase of 60,000 shares made by Fred A Middleton , a net purchase of 28,000 shares made by Martha J Demski , and a net sale of 7,630 shares made by David Jakeman .

In summary, during the past 3 months, insiders sold 0 shares of Chimerix Inc (CMRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,630 shares of Chimerix Inc (CMRX) were sold and 198,750 shares were bought by its insiders, resulting in a net purchase of 191,120 shares.

Chimerix Inc (CMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.


Chimerix Inc Insider Transactions

No Available Data

M Michelle Berrey Mailing Address

Above is the net worth, insider trading, and ownership report for M Michelle Berrey. You might contact M Michelle Berrey via mailing address: 303a College Road East, Princeton Nj 08450.

Discussions on M Michelle Berrey

No discussions yet.